Zhonghong Pulin Medical Products Co., Ltd. (SHE:300981)
China flag China · Delayed Price · Currency is CNY
14.00
-0.50 (-3.45%)
Nov 17, 2026, 3:04 PM CST

SHE:300981 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,7452,3652,4202,0681,5644,901
Other Revenue
8.698.6937.0837.598.888.76
2,7542,3732,4572,1051,5734,909
Revenue Growth
10.96%-3.40%16.69%33.87%-67.97%2.74%
Cost of Revenue
2,1752,1542,1832,0071,5542,026
Gross Profit
579.14219.4273.8398.3118.852,883
Selling, General & Admin
237.99253.26242.37219.06133.55116.2
Research & Development
52.151.0849.731.618.8321.79
Other Operating Expenses
20.7522.0714.8618.4218.6652.96
Operating Expenses
324.4339.66311.65272.5164.53189.78
Operating Income
254.73-120.26-37.82-174.19-145.672,693
Interest Expense
-37.64-31.03-24.09-15.35-1.66-1.61
Interest & Investment Income
77.3671.9978.8767.4742.9439.56
Currency Exchange Gain (Loss)
-25.22-25.2230.079.5735.72-23.98
Other Non Operating Income (Expenses)
-62.05-2.16-2.12-6.01-4.45-2.46
EBT Excluding Unusual Items
207.18-106.6944.91-118.52-73.122,705
Impairment of Goodwill
-65.02-65.02-145.85-71.89--
Gain (Loss) on Sale of Investments
22.0842.8648.1160.1951.4661.34
Gain (Loss) on Sale of Assets
-0.790.730.850.87-0.213.18
Asset Writedown
-9.68-7.77-29.78-28.04-11.48-18.38
Other Unusual Items
13.6211.7814.8619.7184.6233.37
Pretax Income
167.38-124.11-66.9-137.6751.272,784
Income Tax Expense
21.51-7.6318.93-10-15.71442.38
Earnings From Continuing Operations
145.86-116.48-85.83-127.6766.982,342
Minority Interest in Earnings
2.144.09-1.3-3.2-0.07-
Net Income
148-112.38-87.13-130.8766.922,342
Net Income to Common
148-112.38-87.13-130.8766.922,342
Net Income Growth
-----97.14%-12.07%
Shares Outstanding (Basic)
433432436423433393
Shares Outstanding (Diluted)
433432436423433393
Shares Change
-0.45%-0.78%2.89%-2.24%10.19%22.18%
EPS (Basic)
0.34-0.26-0.20-0.310.155.96
EPS (Diluted)
0.34-0.26-0.20-0.310.155.96
EPS Growth
-----97.41%-28.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
422.45-186.8976.51-61.46-100.951,384
Free Cash Flow Per Share
0.98-0.430.18-0.14-0.233.52
Dividend Per Share
0.3500.3500.2500.4550.4891.748
Dividend Growth
40.00%40.00%-44.99%-7.15%-72.00%12.50%
Gross Margin
21.03%9.25%11.15%4.67%1.20%58.73%
Operating Margin
9.25%-5.07%-1.54%-8.27%-9.26%54.86%
Profit Margin
5.37%-4.74%-3.55%-6.22%4.25%47.70%
Free Cash Flow Margin
15.34%-7.88%3.11%-2.92%-6.42%28.19%
EBITDA
471.3794.82175.1925.66-1.692,772
EBITDA Margin
17.12%4.00%7.13%1.22%-0.11%56.46%
D&A For EBITDA
216.64215.08213.01199.84143.9878.68
EBIT
254.73-120.26-37.82-174.19-145.672,693
EBIT Margin
9.25%-5.07%-1.54%-8.27%-9.26%54.86%
Effective Tax Rate
12.85%----15.89%
Revenue as Reported
2,7542,3732,4572,1051,5734,909
Advertising Expenses
-15.7312.058.784.865.49